4.2 Article

Glioblastoma Multiforme Treatment with Clinical Trials for Surgical Resection (Aminolevulinic Acid)

Journal

NEUROSURGERY CLINICS OF NORTH AMERICA
Volume 23, Issue 3, Pages 371-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.nec.2012.04.001

Keywords

5-ALA; Fluorescence; Glioma; Surgery

Funding

  1. National Institutes of Health [R01NS052274-01A2, K25CA138578]

Ask authors/readers for more resources

5-Aminolevulinic acid (5-ALA)-induced tumor fluorescence can be used to identify tissue for resection using an adapted operating microscope. A multi-institutional clinical trial comparing fluorescence-guided versus white light tumor resection reported significant improvement in completeness of resection and 6-month progression-free survival. The degree of 5-ALA-induced fluorescence correlates with histopathologic grade of tumor, degree of tumor cell infiltration, and proliferation indices. Quantitative methodologies for assessment of tissue fluorescence have significantly improved the ability to detect tumor tissue and intraoperative diagnostic performance. These developments extend the applicability of this technology to additional tumor histologies and provide the rationale for further instrumentation development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available